Proshares Ultra Nasd BiotechBIBETF

13F holders, Q4 2025 (December 31)
19holders
2new positions
2sold out
$79.80avg. 13F price*

At the end of Q4 2025, 19 institutions reported holding Proshares Ultra Nasd Biotech (BIB) in their 13F filings, unchanged from Q3 2025. 2 opened new positions and 2 sold out. The largest holders were Susquehanna International Group, LLP ($514K), Capital Investment Advisors, LLC ($478K) and Kaizen Financial Strategies ($424K).

Company
Proshares Ultra Nasd Biotech
CUSIP
74347R214
Latest filing quarter
Q2 2026

History

Number of 13F holders

0510152025 Q1 2024: 21Q1 2024Q2 2024: 24Q2 2024Q3 2024: 21Q3 2024Q4 2024: 24Q4 2024Q1 2025: 23Q1 2025Q2 2025: 17Q2 2025Q3 2025: 19Q3 2025Q4 2025: 19Q4 2025Q1 2026: 23Q1 2026Q2 2026: 20Q2 2026

Total Exit/New Position Q3 2025 → Q4 2025

InstitutionsTotal Value
New Positions2$425K
Exits2$841K

All 13F filers, Q3 2025 → Q4 2025: 5,708 shares bought and 30,752 shares sold, net −25,044 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 19 holders
Susquehanna International Group, LLP 0.00% Reduce -54.4% 6,437 $514K
Capital Investment Advisors, LLC 0.01% Reduce -1.6% 5,996 $478K
Kaizen Financial Strategies 0.19% New 5,315 $424K
Palumbo Wealth Management LLC 0.08% Reduce -68.9% 4,000 $319K
Toth Financial Advisory Corp. 0.01% No change 997 $80K
Tower Research Capital LLC (TRC) 0.00% Add +68.1% 938 $75K
Royal Bank of Canada 0.00% No change 800 $64K
Franklin Resources Inc. 0.00% No change 696 $56K
PNC Financial Services Group, Inc. 0.00% No change 500 $40K
MAI Capital Management 0.00% No change 250 $20K
Northwestern Mutual Wealth Management Co. 0.00% No change 204 $16K
Harel Insurance Investments & Financial Services Ltd. 0.00% No change 198 $16K
Truvestments Capital LLC 0.00% No change 125 $10K
Whittier Trust Co. 0.00% No change 75 $6K
Qube Research & Technologies Ltd 0.00% No change 53 $4K
Simplex Trading, LLC 0.00% New 12 $957
Wells Fargo & Company 0.00% Add +100.0% 2 $145
Morgan Stanley 0.00% No change 1 $125
UBS Group AG 0.00% No change 1 $80

"% of holder's portfolio" is BIB's weight in each manager's 13F, not the share of Proshares Ultra Nasd Biotech the manager owns.